However, genetic alterations are not ubiquitous, as illustrated by a minority of metastatic castration-resistant prostate cancer presenting as neuroendocrine while retaining diffuse Rb expression tested via IHC [66]. The gene discussed is RB1; the disease is prostate carcinoma.